ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,600.11
      1.23%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. 10x Genomics Inc (TXG)

      7. 10x Genomics Inc (TXG) News

      TXG

      10x Genomics (TXG)

      10x Genomics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:TXG
      DateTimeSourceHeadlineSymbolCompany
      02/20/20244:05PMPR Newswire (US)10x Genomics to Present at the 44th Annual TD Cowen Health Care ConferenceNASDAQ:TXG10x Genomics Inc
      02/15/20245:33PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TXG10x Genomics Inc
      02/15/20245:16PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:TXG10x Genomics Inc
      02/15/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TXG10x Genomics Inc
      02/15/20244:05PMPR Newswire (US)10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024NASDAQ:TXG10x Genomics Inc
      02/13/20244:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
      02/07/20244:05PMPR Newswire (US)10x Genomics Expands Leadership in Single Cell Analysis with Launch of GEM-X TechnologyNASDAQ:TXG10x Genomics Inc
      02/05/20244:05PMPR Newswire (US)10x Genomics to Showcase New Cutting-Edge Technologies and Highlight Innovation Roadmap at 2024 AGBT General MeetingNASDAQ:TXG10x Genomics Inc
      01/24/20244:05PMPR Newswire (US)10x Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024NASDAQ:TXG10x Genomics Inc
      01/18/20244:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
      01/16/20246:08PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXG10x Genomics Inc
      01/16/20244:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TXG10x Genomics Inc
      01/08/20249:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TXG10x Genomics Inc
      01/08/20249:00AMPR Newswire (US)10x Genomics Announces Preliminary Fourth Quarter and Full Year 2023 ResultsNASDAQ:TXG10x Genomics Inc
      12/29/20234:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
      12/29/20234:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
      12/21/20234:05PMPR Newswire (US)10x Genomics to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:TXG10x Genomics Inc
      12/20/20234:05PMPR Newswire (US)10x Genomics Launches Xenium Catalyst NetworkNASDAQ:TXG10x Genomics Inc
      12/19/20239:00AMPR Newswire (US)Integrative Study Conducted by 10x Genomics Combines Single Cell, Spatial and In Situ Analyses to Investigate Tumor InvasivenessNASDAQ:TXG10x Genomics Inc
      12/18/20235:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
      12/14/20235:09PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXG10x Genomics Inc
      12/13/20234:26PMPR Newswire (US)High Sensitivity and Specificity of the Xenium Platform from 10x Genomics Outperforms NanoString's CosMx and Vizgen's Merscope in Benchmarking PreprintNASDAQ:TXG10x Genomics Inc
      12/07/20239:00AMPR Newswire (US)10x Genomics and NIH CARD to Create Comprehensive Single Cell Atlas of the Human BrainNASDAQ:TXG10x Genomics Inc
      11/27/20236:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
      11/27/20236:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
      11/27/20236:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
      11/27/20236:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
      11/22/20234:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
      11/22/20234:25PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXG10x Genomics Inc
      11/22/20234:25PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXG10x Genomics Inc
       Showing the most relevant articles for your search:NASDAQ:TXG